Ivax receives approval for generic Pulmicort Respules

Ivax (now owned by Teva Pharmaceuticals) have received FDA approval to market their generic version of AstraZeneca’s Pulmicort Respules in 0.25mg/ml and 0.5mg/ml strengths. More details here.

0 Responses to “Ivax receives approval for generic Pulmicort Respules”


Comments are currently closed.